Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

18.12.2017

2 Ann Oncol
1 Ann Surg
4 Anticancer Res
1 Br J Cancer
1 Breast Cancer
1 Breast Cancer (Dove Med Press)
1 Breast Cancer Res
11 Breast Cancer Res Treat
2 Cancer
1 Cancer Chemother Pharmacol
3 Cancer Res
1 Cell
6 Clin Breast Cancer
7 Eur J Cancer
1 Eur Radiol
3 Int J Cancer
1 J Clin Invest
2 J Clin Oncol
3 J Natl Cancer Inst
3 JAMA
6 Lancet Oncol
1 Nat Rev Clin Oncol
2 NPJ Breast Cancer
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiology



    Ann Oncol

  1. CONDORELLI R, Spring L, O'Shaughnessy J, Lacroix L, et al
    Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer.
    Ann Oncol. 2017 Dec 11. pii: 4725051. doi: 10.1093.
    >> Share

  2. GENNARI A, Sun Z, Hasler-Strub U, Colleoni M, et al
    A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial.
    Ann Oncol. 2017 Dec 8. pii: 4710349. doi: 10.1093.
    >> Share


    Ann Surg

  3. LANE WO, Thomas SM, Blitzblau RC, Plichta JK, et al
    Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis.
    Ann Surg. 2017 Dec 7. doi: 10.1097/SLA.0000000000002621.
    >> Share


    Anticancer Res

  4. SAPINHO G, Alho I, Bicho M, Coelho C, et al
    Total Knockdown of LMW-PTP in MDA-MB-231 Cells Reduces Osteoclastogenesis.
    Anticancer Res. 2017;37:6671-6677.
    >> Share

  5. MIRKA H, Tupy R, Narsanska A, Hes O, et al
    Pre-surgical Multiparametric Assessment of Breast Lesions Using 3-Tesla Magnetic Resonance.
    Anticancer Res. 2017;37:6965-6970.
    >> Share

  6. CHRISTOPOULOS PF, Vlachogiannis NI, Vogkou CT, Koutsilieris M, et al
    The Role of the Androgen Receptor Signaling in Breast Malignancies.
    Anticancer Res. 2017;37:6533-6540.
    >> Share

  7. MANOUCHEHRI JM, Kalafatis M
    Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-Treatment.
    Anticancer Res. 2017;37:6593-6599.
    >> Share


    Br J Cancer

  8. REDDY SM, Barcenas CH, Sinha AK, Hsu L, et al
    Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity.
    Br J Cancer. 2017 Dec 12. pii: bjc2017379. doi: 10.1038/bjc.2017.
    >> Share


    Breast Cancer

  9. SHIMOI T, Yoshida M, Kitamura Y, Yoshino T, et al
    TERT promoter hotspot mutations in breast cancer.
    Breast Cancer. 2017 Dec 8. pii: 10.1007/s12282-017-0825.
    >> Share


    Breast Cancer (Dove Med Press)

  10. VAN WYHE RD, Rahal OM, Woodward WA
    Effect of statins on breast cancer recurrence and mortality: a review.
    Breast Cancer (Dove Med Press). 2017;9:559-565.
    >> Share


    Breast Cancer Res

  11. PARADA H JR, Sun X, Fleming JM, Williams-DeVane CR, et al
    Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study.
    Breast Cancer Res. 2017;19:131.
    >> Share


    Breast Cancer Res Treat

  12. FANG H, Huang D, Yang F, Guan X, et al
    Potential biomarkers of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer.
    Breast Cancer Res Treat. 2017 Dec 13. pii: 10.1007/s10549-017-4612.
    >> Share

  13. XIE J, Cao J, Wang JF, Zhang BH, et al
    Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study.
    Breast Cancer Res Treat. 2017 Dec 11. pii: 10.1007/s10549-017-4609.
    >> Share

  14. NOMURA SJO, Hwang YT, Gomez SL, Fung TT, et al
    Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors.
    Breast Cancer Res Treat. 2017 Dec 11. pii: 10.1007/s10549-017-4578.
    >> Share

  15. LI W, Kwok CC, Chan DC, Wang F, et al
    Weak circadian rhythm increases neutropenia risk among breast cancer patients undergoing adjuvant chemotherapy.
    Breast Cancer Res Treat. 2017 Dec 11. pii: 10.1007/s10549-017-4614.
    >> Share

  16. SINGH K, He X, Kalife ET, Ehdaivand S, et al
    Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results.
    Breast Cancer Res Treat. 2017 Dec 11. pii: 10.1007/s10549-017-4619.
    >> Share

  17. FALANDRY C, Krakowski I, Cure H, Carola E, et al
    Impact of geriatric assessment for the therapeutic decision-making of breast cancer: results of a French survey. AFSOS and SOFOG collaborative work.
    Breast Cancer Res Treat. 2017 Dec 14. pii: 10.1007/s10549-017-4607.
    >> Share

  18. SPEIGL L, Burow H, Bailur JK, Janssen N, et al
    CD14+ HLA-DR-/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation.
    Breast Cancer Res Treat. 2017 Dec 11. pii: 10.1007/s10549-017-4594.
    >> Share

  19. BLOK EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, et al
    Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer.
    Breast Cancer Res Treat. 2017 Dec 12. pii: 10.1007/s10549-017-4601.
    >> Share

  20. VAN VULPEN JK, Schmidt ME, Velthuis MJ, Wiskemann J, et al
    Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy.
    Breast Cancer Res Treat. 2017 Dec 12. pii: 10.1007/s10549-017-4608.
    >> Share

  21. BENS A, Papadopoulos FC, Pukkala E, Ekbom A, et al
    Worse survival after breast cancer in women with anorexia nervosa.
    Breast Cancer Res Treat. 2017 Dec 12. pii: 10.1007/s10549-017-4618.
    >> Share

  22. HAN SN, Amant F, Cardonick EH, Loibl S, et al
    Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
    Breast Cancer Res Treat. 2017 Dec 12. pii: 10.1007/s10549-017-4611.
    >> Share


    Cancer

  23. ROSENSTOCK AS, Niu J, Giordano SH, Zhao H, et al
    Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients.
    Cancer. 2017 Dec 13. doi: 10.1002/cncr.31144.
    >> Share

  24. OHRI N, Haffty BG, Buchholz TA
    The role of postmastectomy radiotherapy in patients with stage II breast cancer.
    Cancer. 2017 Dec 12. doi: 10.1002/cncr.31130.
    >> Share


    Cancer Chemother Pharmacol

  25. ZHOU X, Qiao G, Wang X, Song Q, et al
    CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine.
    Cancer Chemother Pharmacol. 2017 Dec 14. pii: 10.1007/s00280-017-3500.
    >> Share


    Cancer Res

  26. EL-SHENNAWY L, Dubrovskyi O, Kastrati I, Danes JM, et al
    Coactivation of estrogen receptor and IKK-beta induces a dormant metastatic phenotype in ER-positive breast cancer.
    Cancer Res. 2017 Dec 11. pii: 0008-5472.CAN-17-1686.
    >> Share

  27. TELONIS AG, Rigoutsos I
    Race disparities in the contribution of miRNA isoforms and tRNA-derived fragments to triple-negative breast cancer.
    Cancer Res. 2017 Dec 11. pii: 0008-5472.CAN-17-1947.
    >> Share

  28. PAOLETTI C, Cani AK, Larios JM, Hovelson DH, et al
    Comprehensive mutation and copy number profiling in archived circulating breast cancer tumor cells documents heterogeneous resistance mechanisms.
    Cancer Res. 2017 Dec 12. pii: 0008-5472.CAN-17-2686.
    >> Share


    Cell

  29. SACHS N, de Ligt J, Kopper O, Gogola E, et al
    A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
    Cell. 2017 Dec 5. pii: S0092-8674(17)31319-3. doi: 10.1016/j.cell.2017.
    >> Share


    Clin Breast Cancer

  30. RAGHAVENDRA A, Sinha AK, Valle J, Shen Y, et al
    Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30621.
    >> Share

  31. FIGUEIREDO FWDS, Adami F
    Income Inequality and Mortality Owing to Breast Cancer: Evidence From Brazil.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30526.
    >> Share

  32. LANDMAN Y, Ilouze M, Wein S, Neiman V, et al
    Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion.
    Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30561.
    >> Share

  33. RASOOL I, Afroze D, Wani KA, Yousuf A, et al
    Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30631.
    >> Share

  34. CHKHEIDZE R, Sanders MAG, Haley B, Leitch AM, et al
    Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases.
    Clin Breast Cancer. 2017 Nov 10. pii: S1526-8209(17)30456.
    >> Share

  35. HARDEFELDT PJ, Penninkilampi R, Edirimanne S, Eslick GD, et al
    Physical Activity and Weight Loss Reduce the Risk of Breast Cancer: A Meta-analysis of 139 Prospective and Retrospective Studies.
    Clin Breast Cancer. 2017 Oct 17. pii: S1526-8209(16)30429.
    >> Share


    Eur J Cancer

  36. FUJII T, Matsuda N, Kono M, Harano K, et al
    Prior systemic treatment increased the incidence of somatic mutations in metastatic breast cancer.
    Eur J Cancer. 2017;89:64-71.
    >> Share

  37. BOTTERI E, Krendyukov A, Curigliano G
    Comparing granulocyte colony-stimulating factor filgrastim and pegfilgrastim to its biosimilars in terms of efficacy and safety: A meta-analysis of randomised clinical trials in breast cancer patients.
    Eur J Cancer. 2017;89:49-55.
    >> Share

  38. DI COSIMO S, Campbell C, Azim HA Jr, Galli G, et al
    The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO.
    Eur J Cancer. 2017;89:42-48.
    >> Share

  39. TONG Y, Chen X, Fei X, Lin L, et al
    Can breast cancer patients with HER2 dual-equivocal tumours be managed as HER2-negative disease?
    Eur J Cancer. 2017;89:9-18.
    >> Share

  40. SCHNEEWEISS A, Chia S, Hickish T, Harvey V, et al
    Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positiv
    Eur J Cancer. 2017;89:27-35.
    >> Share

  41. LUND E, Nakamura A, Thalabard JC
    No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study.
    Eur J Cancer. 2017;89:102-112.
    >> Share

  42. NIXON NA, Hannouf MB, Verma S
    A review of the value of human epidermal growth factor receptor 2 (HER2)-targeted therapies in breast cancer.
    Eur J Cancer. 2017;89:72-81.
    >> Share


    Eur Radiol

  43. RODRIGUEZ-RUIZ A, Gubern-Merida A, Imhof-Tas M, Lardenoije S, et al
    One-view digital breast tomosynthesis as a stand-alone modality for breast cancer detection: do we need more?
    Eur Radiol. 2017 Dec 11. pii: 10.1007/s00330-017-5167.
    >> Share


    Int J Cancer

  44. MA L, Fu Q, Xu B, Zhou H, et al
    Breast cancer-associated mitochondrial DNA haplogroup promotes neoplastic growth via ROS-mediated AKT activation.
    Int J Cancer. 2017 Dec 11. doi: 10.1002/ijc.31207.
    >> Share

  45. CHEN J, Yao Q, Huang M, Wang B, et al
    A Randomized Phase III Trial of Neoadjuvant Recombinant Human Endostatin, Docetaxel and Epirubicin as First-Line Therapy for Patients with Breast Cancer (CBCRT01).
    Int J Cancer. 2017 Dec 14. doi: 10.1002/ijc.31217.
    >> Share

  46. XIE X, Tan W, Chen B, Huang X, et al
    Preoperative prediction nomogram based on primary tumor miRNAs signature and clinical-related features for axillary lymph node metastasis in early-stage invasive breast cancer.
    Int J Cancer. 2017 Dec 11. doi: 10.1002/ijc.31208.
    >> Share


    J Clin Invest

  47. SUN Q, Lesperance J, Wettersten H, Luterstein E, et al
    Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis.
    J Clin Invest. 2017 Dec 11. pii: 93707. doi: 10.1172/JCI93707.
    >> Share


    J Clin Oncol

  48. JOHNSTON SRD, Hegg R, Im SA, Park IH, et al
    Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Br
    J Clin Oncol. 2017 Dec 15:JCO2017747824. doi: 10.1200/JCO.2017.74.7824.
    >> Share

  49. BLUM JL, Robert N, Andersen J, Favret A, et al
    Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.
    J Clin Oncol. 2017 Dec 11:JCO2017753756. doi: 10.1200/JCO.2017.75.3756.
    >> Share


    J Natl Cancer Inst

  50. GLUZ O, Nitz U, Liedtke C, Christgen M, et al
    Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
    J Natl Cancer Inst. 2017 Dec 8. pii: 4698155. doi: 10.1093.
    >> Share

  51. KURIAN AW, Bondarenko I, Jagsi R, Friese CR, et al
    Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
    J Natl Cancer Inst. 2017 Dec 11. pii: 4718501. doi: 10.1093.
    >> Share

  52. POORVU PD, Winer EP
    Adjuvant Chemotherapy for ER+ Breast Cancer: A Sea Change is Underway.
    J Natl Cancer Inst. 2017 Dec 11. pii: 4718502. doi: 10.1093.
    >> Share


    JAMA

  53. GOLDEN JA
    Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer: Helping Artificial Intelligence Be Seen.
    JAMA. 2017;318:2184-2186.
    >> Share

  54. EHTESHAMI BEJNORDI B, Veta M, Johannes van Diest P, van Ginneken B, et al
    Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.
    JAMA. 2017;318:2199-2210.
    >> Share

  55. ENGELHARDT KE, Barnard C, Bilimoria KY
    Wrong-Site Surgery.
    JAMA. 2017;318:2033-2034.
    >> Share


    Lancet Oncol

  56. DERKS MGM, van de Velde CJH
    Neoadjuvant chemotherapy in breast cancer: more than just downsizing.
    Lancet Oncol. 2017 Dec 11. pii: S1470-2045(17)30914.
    >> Share


  57. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
    Lancet Oncol. 2017 Dec 11. pii: S1470-2045(17)30777.
    >> Share

  58. SALGADO R, Loi S
    Tumour infiltrating lymphocytes in breast cancer: increasing clinical relevance.
    Lancet Oncol. 2017 Dec 7. pii: S1470-2045(17)30905.
    >> Share

  59. HO AY, Hu ZI, Mehrara BJ, Wilkins EG, et al
    Radiotherapy in the setting of breast reconstruction: types, techniques, and timing.
    Lancet Oncol. 2017;18:e742-e753.
    >> Share

  60. DI LEO A, Johnston S, Lee KS, Ciruelos E, et al
    Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet Oncol. 2017 Dec 6. pii: S1470-2045(17)30688.
    >> Share

  61. DENKERT C, von Minckwitz G, Darb-Esfahani S, Lederer B, et al
    Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
    Lancet Oncol. 2017 Dec 7. pii: S1470-2045(17)30904.
    >> Share


    Nat Rev Clin Oncol

  62. PEREZ-GARCIA J, Cortes J
    Breast cancer in 2017: Spurring science, marking progress, and influencing history.
    Nat Rev Clin Oncol. 2017 Dec 12. pii: nrclinonc.2017.
    >> Share


    NPJ Breast Cancer

  63. SCURIC Z, Carroll JE, Bower JE, Ramos-Perlberg S, et al
    Biomarkers of aging associated with past treatments in breast cancer survivors.
    NPJ Breast Cancer. 2017;3:50.
    >> Share

  64. LITTON JK, Scoggins M, Ramirez DL, Murthy RK, et al
    A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline BRCA mutation demonstrates marked activity.
    NPJ Breast Cancer. 2017;3:49.
    >> Share


    PLoS One

  65. HENDERSON HJ, Karanam B, Samant R, Vig K, et al
    Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival.
    PLoS One. 2017;12:e0189662.
    >> Share

  66. ZEINOMAR N, Thai A, Cloud AJ, McDonald JA, et al
    Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry.
    PLoS One. 2017;12:e0189118.
    >> Share


    Proc Natl Acad Sci U S A

  67. DOHERTY MR, Cheon H, Junk DJ, Vinayak S, et al
    Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1713728114.
    >> Share


    Radiology

  68. HOFVIND S, Sagstad S, Sebuodegard S, Chen Y, et al
    Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
    Radiology. 2017 Dec 14:162159. doi: 10.1148/radiol.2017162159.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016